Skip to main content
. 2019 Aug 13;10(48):4987–5002. doi: 10.18632/oncotarget.27080

Table 3. Clinical and immunophenotypic characteristics of the samples used for methylome analysis.

  Clinical and immunophenotypic characteristics
CLL patients Sample ID Age Sex Smoking status BMI CD5+ (%) CD5+/CD19+ (%) CD23+ (%) CD38+ (%) IGHV mutational status Lymphocyte count/mm3 SHANK1 Methylation value (%)
304012 002 67 M No Smoker 19,6 NA NA NA NA NA NA 59
304012 007 81 M No Smoker 23,8 93.30 71.50 72.10 42 Positive 5050 23
304012 030 67 M No Smoker 27,2 98.60 92 92 2.6 Negative 32380 51
304012 048 64 F No Smoker 26,7 94.1 78.70 75.40 15 Negative 9580 57
304032 083 75 M Smoker 32,9 NA NA NA NA NA NA 75
304012 088 79 M No Smoker 33,8 98.2 91 91.4 4.7 Negative 45330 63
304012 092 64 M No Smoker 26,9 88.7 64.8 63.7 10 Positive 21830 32
304012 112 83 F No Smoker NA 34 6 70.3 14 Negative 5270 27
304012 114 73 M No Smoker 25,5 Negative/ weak NA 65 16 Negative 24360 36
304012 188 43 F No Smoker 21,0 97 87 88 9 Positive 5410 16
304012 193 52 M Smoker 30,8 56 NA NA NA Negative 58880 69
304012 196 58 F No Smoker 18,6 68 54 76 NA Negative 9060 44
304012 198 48 F No Smoker 21,9 NA NA NA NA NA NA 10
304012 475* 60 M No Smoker 23,0 97.9 94.60 Partially expressed Weak Positive 94100 69
Controls 304012 357 37 F No Smoker 24,7 9
304012 368 68 M No Smoker 30,8 10
304012 427 47 M No Smoker 26,8 10
304012 429 69 M No Smoker 28,1 13
304012 448 67 F No Smoker 21,7 16
304012 455 20 M Smoker 21,7 8

For 4/18 patients with CLL diagnosis used for methylome analysis, clinical and immunophenotypic characteristics were not available. * this patient was firstly diagnosed as Follicular lymphoma.